SAFFRON-103: a phase 1b study of the safety and efficacy of sitravatinib combined with tislelizumab in patients with locally advanced or metastatic non-small cell lung cancer
==============================================================================================================================================================================

* Jun Zhao
* Xinmin Yu
* Dingzhi Huang
* Zhiyong Ma
* Bo Gao
* Jiuwei Cui
* Qian Chu
* Qing Zhou
* Meili Sun
* Daphne Day
* Jingxun Wu
* Hongming Pan
* Lifeng Wang
* Mark Voskoboynik
* Zhehai Wang
* Yunpeng Liu
* Hui Li
* Juan Zhang
* Yanyan Peng
* Yi-Long Wu